Metformin, SGLT2 inhibitors, Sulfonylureas, Insulins.

0.0(0)
studied byStudied by 0 people
0.0(0)
call with kaiCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/65

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 8:34 PM on 1/26/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

66 Terms

1
New cards

What class of drug is metformin?

Biguanide.

2
New cards

How does metformin lower blood glucose?

1) Reducing glycogenolysis and gluconeogenesis

2) Increasing glucose uptake and utilisation by skeletal muscle

3) Activation of AMP kinase

3
New cards

What beneficial metabolic effect may accompany metformin therapy?

Modest weight loss.

4
New cards

How is metformin eliminated from the body?

Excreted unchanged by the kidneys.

5
New cards

When should metformin dose be reduced based on eGFR?

eGFR <45 mL/min/1.73 m²

6
New cards

When should metformin be STOPPED due to renal function?

eGFR <30 mL/min/1.73 m²

7
New cards

In which acute conditions should metformin be withheld?

AKI or severe tissue hypoxia (e.g. sepsis, MI, respiratory failure).

8
New cards

Why should metformin be used cautiously in liver disease?

Reduced lactate clearance increases lactic acidosis risk.

9
New cards

What advice applies to alcohol and metformin use?

Withhold during acute intoxication; caution in chronic alcohol abuse.

10
New cards

What must be checked before giving IV iodinated contrast to a patient on metformin?

Renal function.

11
New cards

Why may metformin be temporarily stopped around contrast studies? Does this apply to gadolinium-based contrast agents used for MRI scans?

1) Risk of renal impairment → lactic acidosis.

2) No.

12
New cards

Which drugs increase the risk of renal impairment when combined with metformin?

ACE inhibitors, NSAIDs, diuretics.

13
New cards

Which drugs oppose the glucose-lowering effect of metformin?

Corticosteroids, thiazide diuretics, loop diuretics.

14
New cards

What is the usual HbA1c target on metformin monotherapy?

≤48 mmol/mol.

15
New cards

How often should renal function be monitored with metformin?

Before starting and at least annually (more often if high risk).

16
New cards

When should metformin be stopped?

Intolerance, lack of efficacy, eGFR <30 mL/min/1.73 m², or acute illness.

17
New cards

Why is metformin usually the first-choice drug in type 2 diabetes?

Effective glucose control without weight gain or hypoglycaemia.

18
New cards

What are the common indications of SGLT2 inhibitors?

1) T2DM

2) HF with reduced ejection fraction

3) CKD with albuminuria

19
New cards

Where is SGLT2 located in the nephron?

PCT.

20
New cards

How do SGLT2 inhibitors lower blood glucose?

By inhibiting glucose reabsorption, causing glycosuria.

21
New cards

What effect do SGLT2 inhibitors have on sodium and water excretion?

Increases both.

22
New cards

What effect do SGLT2 inhibitors have on intraglomerular pressure?

Reduce it via tubuloglomerular feedback.

23
New cards

Do SGLT2 inhibitors commonly cause hypoglycaemia? Why?

No- their effect diminishes at low serum glucose levels.

24
New cards

Why do SGLT2 inhibitors increase infection risk?

Glycosuria promotes bacterial and fungal growth.

25
New cards

What rare but serious infection is associated with SGLT2 inhibitors?

Fournier’s gangrene.

26
New cards

What type of ketoacidosis can SGLT2 inhibitors cause?

Euglycaemic diabetic ketoacidosis. (DKA at near-normal glucose levels).

27
New cards

How do SGLT2 inhibitors interact with antihypertensive drugs?

Increase risk of hypotension.

28
New cards

How do SGLT2 inhibitors interact with diuretics?

Increase risk of volume depletion.

29
New cards

Can SGLT2 inhibitors be taken with food?

Yes.

30
New cards

What should be checked before starting SGLT2 inhibitors?

Renals- then continued annually.

31
New cards

When should SGLT2 inhibitors be temporarily STOPPED?

During dehydration, hypovolaemia, hypotension, or acute illness.

32
New cards

What urinalysis finding is concerning in patients on SGLT2 inhibitors? What action should be taken?

Urinary ketones- withhold drug, check acid–base status, seek specialist advice.

33
New cards

Name some sulfonylureas.

Gliclazide, glimepride, glipizide.

34
New cards

MOA of sulfonylureas?

Stimulating pancreatic insulin secretion, by blocking ATP-dependent K+ channels in pancreatic β-cell membranes

35
New cards

Are sulfonylureas effective in type 1 diabetes?

No – they require residual pancreatic β-cell function.

36
New cards

What is the most important adverse effect of sulfonylureas?

Hypoglycaemia.

37
New cards

When is hypoglycaemia more likely with sulfonylureas?

1) At high doses

2) Reduced drug metabolism

3) In combination with other glucose-lowering drugs

38
New cards

What rare hypersensitivity reactions can sulfonylureas cause?

Cholestatic jaundice, drug hypersensitivity syndrome, agranulocytosis.

39
New cards

How is gliclazide metabolised?

Hepatically.

40
New cards

In which conditions should sulfonylureas be used with caution?

Renal impairment, hepatic impairment, malnutrition, adrenal or pituitary insufficiency, older age.

41
New cards

Which drugs can mask symptoms of hypoglycaemia?

β-blockers.

42
New cards

Which drugs reduce the efficacy of sulfonylureas?

Corticosteroids, thiazide/ loop diuretics.

43
New cards

Why is gliclazide (short-acting) preferred?

Lower risk of nocturnal hypoglycaemia.

44
New cards

What is the approximate equivalence between MR and standard-release gliclazide?

30 mg MR ≈ 80 mg standard-release.

45
New cards

When should sulfonylureas be taken?

With meals.

46
New cards

How should hypoglycaemia be managed by patients?

Take fast-acting sugar, then a starchy snack, and seek advice if symptoms recur.

47
New cards

Why may insulin be preferred during acute illness?

Oral agents are less effective and risk hypoglycemia; insulin is easier to titrate.

48
New cards

In which diabetic emergencies is IV insulin used?

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemic state (HHS).

49
New cards

Why is insulin used peri-operatively?

For tight glycaemic control in selected surgical patients.

50
New cards

How is insulin used in hyperkalaemia?

To shift K⁺ into cells (must be given with IV glucose).

51
New cards

How does insulin lower blood glucose?

1) ↑ Glycogen synthesis, lipid synthesis, and protein synthesis

2) ↓ gluconeogenesis

52
New cards

How does insulin reduce serum potassium?

By activating Na⁺/K⁺-ATPase, driving K⁺ into cells.

53
New cards

Give an example of biphasic insulin.

NovoMix® 30.

54
New cards

Which insulin is used intravenously?

Soluble insulin (Actrapid®).

55
New cards

What is the most important adverse effect of insulin?

Hypoglycaemia.

56
New cards

What local complication can occur with repeated injections at the same site?

Lipohypertrophy.

<p>Lipohypertrophy.</p>
57
New cards

Why is hypoglycaemia risk increased in renal impairment with insulin?

Reduced clearance.

58
New cards

What is a basal-bolus insulin regimen?

1) Long-acting insulin once daily +

2) Rapid-acting insulin with meals.

59
New cards

What is a twice-daily insulin regimen?

Intermediate-acting / biphasic insulin before breakfast and evening meal.

60
New cards

What symptoms indicate hypoglycaemia?

Dizziness, sweating, nausea, agitation, confusion.

61
New cards

What is the main method of monitoring insulin therapy?

Capillary blood glucose measurements.

62
New cards

What must be monitored during IV insulin therapy?

Serum potassium.

63
New cards

What is the acceptable inpatient glucose range in acute illness?

Approximately 4–12 mmol/L.

64
New cards

How should insulin doses be adjusted for hyperglycaemia?

Increase preceding dose by ~10%.

65
New cards

How should insulin doses be adjusted for hypoglycaemia?

Reduce preceding dose by ~20%

66
New cards

Which insulin is preferred for correcting acute hyperglycaemia?

Rapid-acting insulin (e.g. insulin aspart)